Status:
WITHDRAWN
Remimazolam Versus Propopol Based Total Intravenous Anesthesia for Breast Surgery
Lead Sponsor:
Seoul National University Hospital
Conditions:
Hypotension
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Comparison of the incidence of hypotension under remimazolam and propofol-based anesthesia in patients undergoing breast surgery under general anesthesia
Detailed Description
The purpose of this study was to investigate whether remimazolam-based general anesthesia could reduce the incidence of hypotension in patients undergoing breast surgery under general anesthesia compa...
Eligibility Criteria
Inclusion
- Adult patients over the age of 19 undergoing elective breast cancer surgery under general anesthesia at Seoul National University Hospital
Exclusion
- patients with acute narrow-angle glaucoma/ shock or coma/ acute alcohol poisoning/ sleep apnea/ alcohol or drug dependency/ severe or acute respiratory failure/ galactose intolerance/ Lapp lactase deficiency/ glucose galactose malabsorption/ severe hypersensitivity to dextran.
- Patients with myasthenia gravis/ pulmonary heart disease/ chronic obstructive pulmonary disease/ bronchial asthma
- Patients with cardiovascular diseases such as ischemic heart disease/ coronary artery disease/ angina pectoris/ myocardial infarction/ atherosclerosis/ arrhythmia/ cerebrovascular disease/ and stroke
- Patients with chronic renal failure
- Patients with severe hepatic impairment (Child Pugh class C)
- Patients with American Society of Anesthesiology score III or higher
- Patients with hypersensitivity to propofol and soy or peanuts
- Epilepsy patients
- Patient with fat metabolism abnormality
- Patients with high intracranial pressure
- Pregnant woman
- Patients unable to use supraglottic airway due to poor dental condition
- In cases that the researcher judges to be unsuitable for this clinical trial
Key Trial Info
Start Date :
June 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05375747
Start Date
June 13 2022
End Date
January 9 2023
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080